E 
4,200
+0.84%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in KRW, from our data supplier.
Revenue
₩5.26bn
FY2021FY2025
Net income
−₩16.11bn
FY2021FY2025
Free cash flow
−₩13.35bn
FY2021FY2025
Shareholders' equity
₩39.40bn
FY2021FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | ₩5.26bn | ₩7.21bn | ₩10.53bn | ₩7.37bn | ₩3.91bn |
| Research and development | ₩7.73bn | ₩6.64bn | ₩6.07bn | ₩5.73bn | ₩2.10bn |
| Operating income | −₩17.84bn | −₩15.68bn | −₩3.88bn | −₩9.32bn | — |
| Net income | −₩16.11bn | −₩15.21bn | −₩5.05bn | −₩45.57bn | −₩6.58bn |
| Diluted earnings per share | -1,464.12 | -1,412.74 | -540.49 | -4,873.50 | -703.63 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Total assets | ₩63.71bn | ₩55.75bn | ₩43.98bn | ₩54.75bn | ₩38.57bn |
| Cash and short-term investments | — | ₩30.58bn | ₩18.69bn | ₩27.80bn | — |
| Total liabilities | ₩24.31bn | ₩7.58bn | ₩5.96bn | ₩78.58bn | ₩42.20bn |
| Debt | ₩9.00bn | ₩5.15bn | ₩4.42bn | ₩26.12bn | ₩22.60bn |
| Shareholders' equity | ₩39.40bn | ₩48.17bn | ₩38.02bn | −₩23.84bn | −₩3.63bn |
| Shares outstanding | 11m | 11m | 9m | 9m | 9m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Cash from operations | −₩10.20bn | −₩10.10bn | −₩6.44bn | −₩6.96bn | −₩2.33bn |
| Capital spending | −₩3.15bn | −₩641.3m | −₩1.94bn | −₩4.36bn | −₩10.11bn |
| Free cash flow | −₩13.35bn | −₩10.74bn | −₩8.38bn | −₩11.32bn | −₩12.44bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩868.0m | ₩308.9m | ₩1.44bn | ₩1.55bn | ₩1.18bn | ₩1.09bn | ₩2.09bn | ₩1.47bn |
| Operating income | −₩6.81bn | −₩4.85bn | −₩4.94bn | −₩3.66bn | −₩4.47bn | −₩4.77bn | −₩5.51bn | −₩4.15bn |
| Net income | −₩7.23bn | −₩5.26bn | −₩3.53bn | −₩3.60bn | −₩4.33bn | −₩4.65bn | −₩5.20bn | −₩4.07bn |
| Diluted earnings per share | -657.25 | -478.16 | -320.49 | -330.48 | -397.25 | -430.26 | -482.55 | -381.73 |
| Cash from operations | −₩2.24bn | −₩3.00bn | −₩3.43bn | −₩1.36bn | −₩3.59bn | −₩1.81bn | −₩10.10bn | −₩7.33bn |
| Capital spending | −₩640.0m | −₩611.0m | −₩2.01bn | −₩38.0m | −₩514.0m | −₩584.0m | −₩641.0m | −₩611.0m |
| Free cash flow | −₩2.88bn | −₩3.61bn | −₩5.44bn | −₩1.40bn | −₩4.11bn | −₩2.40bn | −₩10.74bn | −₩7.94bn |
| Total assets | ₩55.08bn | ₩60.36bn | ₩63.71bn | ₩44.09bn | ₩47.00bn | ₩51.93bn | ₩55.75bn | ₩58.18bn |
| Cash and short-term investments | — | — | — | — | — | ₩27.64bn | ₩30.58bn | ₩33.78bn |
| Debt | ₩9.77bn | ₩9.24bn | ₩9.00bn | ₩325.0m | ₩400.0m | ₩3.31bn | ₩3.75bn | ₩2.66bn |
| Shareholders' equity | ₩27.86bn | ₩34.96bn | ₩39.40bn | ₩36.45bn | ₩40.13bn | ₩43.89bn | ₩48.17bn | ₩52.47bn |
Financial ratios
Data as of 6 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Operating margin | -339.3% | -217.5% | -36.9% | -126.4% | — |
| Net margin | -306.3% | -211.0% | -48.0% | -618.5% | -168.3% |
| Return on equity | -40.9% | -31.6% | -13.3% | 191.2% | 181.1% |
| Return on assets | -25.3% | -27.3% | -11.5% | -83.2% | -17.1% |
| Revenue growth | -27.1% | -31.5% | 42.9% | 88.5% | — |
| Earnings growth | 5.9% | 201.0% | -88.9% | 592.6% | — |
| Current ratio | 13.59x | 13.22x | 8.36x | 0.43x | 0.51x |
| Debt to equity | 0.23x | 0.01x | 0.02x | -0.05x | -0.40x |
| Equity ratio | 61.8% | 86.4% | 86.4% | -43.5% | -9.4% |
| Interest coverage | -29.04x | -37.15x | -2.01x | -3.13x | — |
| R&D as a share of sales | 147.0% | 92.1% | 57.7% | 77.8% | 53.6% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -10.6% | — | — |
| Operating income | 24.2% | — | — |
| Net income | -29.3% | — | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | |
|---|---|---|
| Price to earnings | -12.4 | -12.3 |
| Price to sales | 38.0 | 25.8 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.